insulin drugs glp 1 receptor agaonist market GLP-1 Agonist Size, Trends and Share Report 2026 GLP-1 Agonists Weight Loss Drugs
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 4
Carvalho, T
Diabetic Retinopathy: Patients with diabetes are at an increased risk for developing diabetic retinopathy due to uncontrolled blood sugar levels
Kim MK, Baek KH, Song KH, Il Kang M, Park CY, Lee WY, et al
Common symptoms include headache, transient visual obscurations, and papilledema, which can lead to visual impairment or blindness if left untreated (1,2)
